Article info
Congenital heart disease
Original research article
Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome
- Correspondence to Dr Clare Arnott, Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, 2050, NSW, Australia; carn8379{at}med.usyd.edu.au
Citation
Pulmonary vasodilator therapy is associated with greater survival in Eisenmenger syndrome
Publication history
- Received May 17, 2017
- Revised July 24, 2017
- Accepted July 26, 2017
- First published August 9, 2017.
Online issue publication
January 18, 2021
Article Versions
- Previous version (18 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.